Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM Study. | Hemasphere | 2023 | 37901848 | PubTator, text mining | PubMed |
| Toxicity of targeted anticancer treatments on the liver in myeloproliferative neoplasms. | World J Hepatol | 2023 | 37900211 | PubTator, text mining | PubMed |
| MicroRNA Expression Patterns Reveal a Role of the TGF-β Family Signaling in AML Chemo-Resistance. | Cancers (Basel) | 2023 | 37894453 | PubTator, text mining | PubMed |
| A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis. | Cancers (Basel) | 2023 | 37894394 | PubTator, text mining | PubMed |
| The Role of Reirradiation in Childhood Progressive Diffuse Intrinsic Pontine Glioma (DIPG): An Ongoing Challenge beyond Radiobiology. | Brain Sci | 2023 | 37891817 | PubTator, text mining | PubMed |
| The Link between Trace Metal Elements and Glucose Metabolism: Evidence from Zinc, Copper, Iron, and Manganese-Mediated Metabolic Regulation. | Metabolites | 2023 | 37887373 | PubTator, text mining | PubMed |
| Characterization of erythroferrone structural domains relevant to its iron-regulatory function. | J Biol Chem | 2023 | 37866631 | PubTator, text mining | PubMed |
| RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort. | Leukemia | 2023 | 37864122 | PubTator, text mining | PubMed |
| Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations. | Acta Neuropathol | 2023 | 37851269 | PubTator, text mining | PubMed |
| Cartilage tissue from sites of weight bearing in patients with osteoarthritis exhibits a differential phenotype with distinct chondrocytes subests. | RMD Open | 2023 | 37848267 | PubTator, text mining | PubMed |
| A Haspin-ARHGAP11A axis regulates epithelial morphogenesis through Rho-ROCK dependent modulation of LIMK1-Cofilin. | iScience | 2023 | 37841592 | PubTator, text mining | PubMed |
| An interactive resource of molecular signalling in the developing human haematopoietic stem cell niche. | Development | 2023 | 37840454 | PubTator, text mining | PubMed |
| Decoding Diffuse Midline Gliomas: A Comprehensive Review of Pathogenesis, Diagnosis and Treatment. | Cancers (Basel) | 2023 | 37835563 | PubTator, text mining | PubMed |
| Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. | Mol Cancer | 2023 | 37833788 | PubTator, text mining | PubMed |
| The Pharmacokinetic Profile of Palovarotene: An Open-Label Phase I Trial Investigating the Effect of Food and Potential for Drug-Drug Interaction in Healthy Participants. | Eur J Drug Metab Pharmacokinet | 2023 | 37804430 | PubTator, text mining | PubMed |
| Epigenomic signature of major congenital heart defects in newborns with Down syndrome. | Hum Genomics | 2023 | 37803336 | PubTator, text mining | PubMed |
| Head and neck manifestations of fibrodysplasia ossificans progressiva: Clinical and imaging findings in 2 cases. | Imaging Sci Dent | 2023 | 37799735 | PubTator, text mining | PubMed |
| Growth differentiation factor 7 autocrine signaling promotes hepatic progenitor cell expansion in liver fibrosis. | Stem Cell Res Ther | 2023 | 37798809 | PubTator, text mining | PubMed |
| Discovery of a glucocorticoid receptor (GR) activity signature correlates with immune cell infiltration in adrenocortical carcinoma. | J Immunother Cancer | 2023 | 37793855 | PubTator, text mining | PubMed |
| BMP signaling in the development and regeneration of tooth roots: from mechanisms to applications. | Front Cell Dev Biol | 2023 | 37779895 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=12